Home » Topics » Regulatory » EMA

EMA
RSS

EMA issues positive opinion on the MAA for SomaKit TOC

Sep. 20, 2016

Pfizer receives positive CHMP opinion for Ibrance in Europe

Sep. 19, 2016

EMA committee grants positive opinion for conditional approval of Ninlaro

Sep. 19, 2016

EMA committee recommends approval of Parsabiv in E.U.

Sep. 19, 2016

EMA committee recommends E.U. approval of Stelara for moderate to severely active Crohn's disease

Sep. 19, 2016

EMA's CHMP recommends approval of Glyxambi for adults with type 2 diabetes

Sep. 19, 2016

EMA's CHMP recommends conditional approval of Lilly's olaratumab

Sep. 16, 2016

EMA validates Cempra's MAA for solithromycin

Aug. 24, 2016

COMP grants orphan drug designation to AB Science's masitinib in ALS

Aug. 9, 2016

EMA accepts for review MAA for sarilumab

Aug. 1, 2016

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...